Pillstats
Rx only · Tablet · Oral

Olmesartan Medoxomil And Hydrochlorothiazide

Hydrochlorothiazide + Olmesartan Medoxomil

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US22 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)5487
US makers6 labelers
Packages70
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 18 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.062$0.125$0.187$0.250Dec 2025Apr 2026Jul 2026
$0.214
Latest avg · Jul 22, 2026
+7%
Since Dec 17, 2025
6
Active US suppliers
61%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.2K16K25K33K2025 Q12025 Q22025 Q32025 Q42026 Q1
27K
Rx · 2026 Q1
1.3M
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown30SUPPLYING
Bryant Ranch Prepackrepackager13SUPPLYING
Lifestar Pharma LLCunknown12SUPPLYING
Solco Healthcare US, LLCunknown9SUPPLYING
A-S Medication Solutionsunknown5SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.